Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Lymphoma, Follicular 1Glioblastoma 1Astrocytoma 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Bevacizumab 2relatlimab 1aldesleukin 1TPI-287 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Nivolumab 1Niacinamide 1Niacin 1Metformin 1Lomustine 1Immunoglobulin G 1Disulfides 1Diet, Ketogenic 1Craniotomy 1Carboplatin 1Biopsy 1Biological Specimen Banks 1ACT001 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Glioblastoma × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all
NCT06860594 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

National Cancer Institute (NCI)

Phase 1 Suspended
30 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡